American Research & Management Company Portfolio holdings
Top Buys
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$2.87M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$1.64M |
| 3 |
NVIDIA
NVDA
|
+$1.08M |
| 4 |
Verizon
VZ
|
+$917K |
| 5 |
Vanguard Short-Term Bond ETF
BSV
|
+$585K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.29% |
| 2 | Miscellaneous | 15.11% |
| 3 | Consumer Staples | 14.86% |
| 4 | Healthcare | 13.86% |
| 5 | Financials | 10.46% |
Similar funds
American Research & Management Company's Q3 2020 Portfolio in Review
As of Q3 2020, American Research & Management Company held 394 positions worth $342M, up 3.9% from $329M the previous quarter. Its ten largest holdings account for 36% of the portfolio.
American Research & Management Company's Q3 2020 filing shows 46 new, 49 increased, 94 reduced and 31 closed positions. Its largest new stake was Service Corp International: 2,450 shares worth $103K. The largest sale was Vertex Pharmaceuticals, an estimated $2.87M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Miscellaneous and Consumer Staples.
- American Research & Management Company's largest Q3 2020 buy was Service Corp International: 2,450 shares worth $103K.
- American Research & Management Company added most to Alerian MLP ETF in Q3 2020, an estimated $6.58M increase.
- American Research & Management Company's biggest Q3 2020 reduction was NVIDIA, cutting an estimated $1.08M.
- American Research & Management Company fully exited Vertex Pharmaceuticals in Q3 2020, selling an estimated $2.87M.
- American Research & Management Company's ten largest holdings make up 36% of its $342M portfolio in Q3 2020.
- American Research & Management Company opened 46 new positions and closed 31 in Q3 2020.
- American Research & Management Company's portfolio value rose 3.9% quarter-over-quarter to $342M.
Based on American Research & Management Company's 13F filing for Q3 2020, filed 29 Oct 2020.